Table 2Poisons implicated in self-poisoning episodes. The figures for each drug are percentages, rounded to the nearest whole number

StudyTownsend et al., 2001Bialas et al., 1996Thomas et al., 1996Kapur et al., 1999
Year of survey19971992–31993–4 (12 weeks)1996 (4 weeks)
LocationOxfordSouth Glamorgannorth-east EnglandLeeds, Manchester, Leicester, Nottingham
Data typepresentations to Oxford general hospitaladmissions to poison treatment centreattendances at 6 A&E departmentsdischarges from A&E at 4 teaching hospitalsadmissions to 4 teaching hospitals
Age groupall agesover 15 yearsover 10 yearsover 16 yearsover 16 years
Total number of episodes13172307945203274
Paracetamol5043434525
Aspirin10.676not statednot stated
All analgesicsnot stated53not statednot statednot stated
Benzodiazepinesnot stated3015not statednot stated
Antidepressants20.11812915
With alcoholnot stated4813not statednot stated

From: 2, Introduction to self-harm

Cover of Self-Harm
Self-Harm: The Short-Term Physical and Psychological Management and Secondary Prevention of Self-Harm in Primary and Secondary Care.
NICE Clinical Guidelines, No. 16.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society; 2004.
Copyright © 2004, The British Psychological Society & The Royal College of Psychiatrists.

All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Enquiries in this regard should be directed to the British Psychological Society.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.